He Xu
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Ferroptosis and cancer prognosis 4
- Prostate Cancer Treatment and Research 3
-
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Yimin Cui (8 shared papers)Yanlun Gu (8 shared papers)Zhiwei Qiu (2 shared papers)Nan Zhao (1 shared paper)Qian Xiang (1 shared paper)Hanxu Zhang (1 shared paper)Xiaocong Pang (1 shared paper)Zhiyan Liu (1 shared paper)
- Journals
- Advanced Healthcare Materials (2 papers)Pharmacological Research (2 papers)Oxidative Medicine and Cellular Longevity (1 paper)British Journal of Cancer (1 paper)International Archives of Allergy and Immunology (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
He Xu
12 papers receiving 763 citations
He Xu's Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology and Allergy 131
- Cancer Research 106
- Immunology 125
- Biomaterials 75
- Cell Biology 91
Countries citing papers authored by He Xu
This map shows the geographic impact of He Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Xu more than expected).
Fields of papers citing papers by He Xu
This network shows the impact of papers produced by He Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Xu. The network helps show where He Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside He Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting integrin pathways: mechanisms and advances in therapy Hit paper breakdown → | 2023 | 610 |
| 2 | 2021 | 53 | |
| 3 | 2023 | 36 | |
| 4 | 2018 | 22 | |
| 5 | 2024 | 16 | |
| 6 | 2023 | 11 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2024 | 0 | |
| 15 | 2025 | 0 |
About He Xu
He Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Immunology and Cancer Research, having authored 15 papers that have together received 773 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (3 papers), Prostate Cancer Treatment and Research (3 papers), Cell Adhesion Molecules Research (2 papers), interferon and immune responses (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune cells in cancer (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Immunology and Allergy (131 citations), Cancer Research (106 citations), Immunology (125 citations), Biomaterials (75 citations) and Cell Biology (91 citations). He Xu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yimin Cui, Yanlun Gu, Zhiwei Qiu, Nan Zhao, Qian Xiang, Hanxu Zhang, Xiaocong Pang, Zhiyan Liu, Ran Xie and Xiaocong Pang. Their work appears in journals such as Advanced Healthcare Materials, Pharmacological Research, Oxidative Medicine and Cellular Longevity, British Journal of Cancer and International Archives of Allergy and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.